Balyasny Asset Management’s Faeth Therapeutics FTH Stock Holding History
Bought
Maintained
Sold
Other funds holding FTH
BBA
Balyasny Asset Management's FTH Position: Q3 2026 in Review
Balyasny Asset Management increased its Faeth Therapeutics (FTH) stake by 11% in Q3 2026, buying an estimated $3.46M and bringing the position to 1,153,377 shares worth $34.3M. The position accounts for 0.04% of the portfolio, ranked #536.
Balyasny Asset Management first reported a position in FTH in Q1 2021 and has held it in 4 quarters since. 78 funds tracked by Wall St. Rank hold FTH as of Q3 2026.
- Balyasny Asset Management held 1,153,377 shares of Faeth Therapeutics worth $34.3M as of Q3 2026.
- Balyasny Asset Management bought 111,179 Faeth Therapeutics shares in Q3 2026, an estimated $3.46M.
- Faeth Therapeutics made up 0.04% of Balyasny Asset Management's portfolio in Q3 2026, its #536 holding.
- Balyasny Asset Management first reported a position in Faeth Therapeutics in Q1 2021 and has held it in 4 quarters since.
- 78 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q3 2026.
Based on Balyasny Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.